Common use of GRANT OF RESEARCH LICENSES Clause in Contracts

GRANT OF RESEARCH LICENSES. (a) Immusol hereby grants NeoGenesis a nonexclusive, nontransferable, royalty-free license to use Immusol Intellectual Property and Program Intellectual Property owned by Immusol (including Immusol Patent Rights) solely for purposes of conducting the Screening Program and performing NeoGenesis' obligations under the Screening Program. NeoGenesis will not use Immusol Intellectual Property and Program Intellectual Property owned by Immusol for any other purpose, without Immusol's prior written permission and except as otherwise permitted by the licenses granted in Section 4.1. NeoGenesis shall not (i) grant, or attempt to grant, a sublicense under this Section 2.3 to use Immusol Intellectual Property or Program Intellectual Property owned by Immusol to any Person without the express written consent of Immusol or (ii) modify the Targets supplied by Immusol, including, without limitation, the making of any derivatives, analogs, fragments or components thereof. In the event that NeoGenesis does not consume all of the Targets supplied by Immusol in performance of the Screening Program, NeoGenesis will upon completion of the Screening Program with respect to each particular Target, return to Immusol any quantities of such Target and any derivatives, analogs, fragments or components thereof.

GRANT OF RESEARCH LICENSES. (a) Immusol Tularik hereby grants NeoGenesis a nonexclusive, nontransferable, royalty-free license to use Immusol Tularik Intellectual Property and Program Intellectual Property owned by Immusol Tularik (including Immusol Tularik Patent Rights) solely for purposes of conducting the Screening Program and performing NeoGenesis' obligations under the Screening Program. NeoGenesis will not use Immusol Tularik Intellectual Property and Program Intellectual Property owned by Immusol Tularik for any other purpose, without ImmusolTularik's prior written permission and except as otherwise permitted by the licenses granted in Section 4.1Sections 3.1 and 3.2(f). NeoGenesis shall not (i) grant, or attempt to grant, a sublicense under this Section 2.3 2.5 to use Immusol Tularik Intellectual Property or Program Intellectual Property owned by Immusol Tularik to any Person without the express written consent of Immusol Tularik or (ii) modify the Targets supplied by ImmusolTularik, including, without limitation, the making of any derivatives, analogs, fragments or components thereof. In the event that NeoGenesis does not consume all of the Targets supplied by Immusol Tularik in performance of the Screening Program, NeoGenesis will upon completion of the Screening Program with respect to each particular Target, return to Immusol Tularik any quantities of such Target and any derivatives, analogs, fragments or components thereof.